Susquehanna International Group, LLP Biovie Inc. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	SELL	$0.4 - $0.56 $116,800 - $163,520	-292,000 Reduced 94.71%	16,300 $6,000
Q1 2024 May 07, 2024	BUY	$0.53 - $1.89 $120,310 - $429,030	227,000 Added 279.21%	308,300 $163,000
Q4 2023 Feb 14, 2024	BUY	$1.22 - $5.24 $75,030 - $322,260	61,500 Added 310.61%	81,300 $102,000
Q3 2023 Nov 14, 2023	BUY	$2.75 - $5.17 $54,450 - $102,366	19,800 New	19,800 $67,000
Q1 2023 May 16, 2023	BUY	$4.89 - $10.53 $92,421 - $199,017	18,900 New	18,900 $152,000

4.73M

17.2K

27K

Ticker BIVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,165,300
Market Cap $83.6M
Description
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.